BROKERAGES SET $23.50 TARGET PRICE FOR LIPOCINE INC (NASDAQ:LPCN) FDA approval date June 28, 2016 http://www.lmkat.com/2016-06-08-brokerages-set-23-50-target-price-for-lipocine-inc-nasdaqlpcn/